Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001785197 | SCV002025729 | uncertain significance | Multiple mitochondrial dysfunctions syndrome 6 | 2020-04-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002541228 | SCV003706324 | uncertain significance | Inborn genetic diseases | 2022-01-31 | criteria provided, single submitter | clinical testing | The c.661A>G (p.I221V) alteration is located in exon 6 (coding exon 6) of the PMPCB gene. This alteration results from a A to G substitution at nucleotide position 661, causing the isoleucine (I) at amino acid position 221 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |